No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

Micro-Tech Endoscopy Announces Expansion of their SureClip® Portfolio: The Lockado Hemostasis Clip

Editor: What To Know

  • Our team has a wealth of experience in the field and an in-depth understanding of both product and use cases.
  • By partnering with doctors dedicated to innovation, we are committed to bringing better devices to market, with unprecedented speed, at an economical price, and without the burden of contracts.
  • At Micro-Tech, we are more than a medical technology company – we are building a community of healthcare innovators and making health care more value-driven.

Micro-Tech Endoscopy USA recently announced an expansion of its SureClip portfolio – the Lockado Hemostasis Clip. “Lockado’s improved clamping function means that the clip can apply superior closure and retention force to the opposing tissue, and lock it in place,” explained Chris Li, President of Micro-Tech Endoscopy USA. “Additionally, because we added opposing atraumatic teeth in the arms of the clip, customers will appreciate a more secure grip for reliable tissue management.”

Micro-Tech Endoscopy USA reports SureClip became popular with Micro-Tech customers due to its ease of use and ergonomic design. These same benefits continue with Lockado.

The convenient thumb ring allows for comfortable deployment while the rotation grip provides 360-degrees of controlled rotation. Combined, the Lockado offers physicians accuracy, reliability, and added confidence.

Since 2000, Micro-Tech has been focused on creating top-quality products for endoscopic diagnosis and therapeutic medical devices that allow physicians to provide the highest level of care. By partnering with doctors dedicated to innovation, we are committed to bringing better devices to market, with unprecedented speed, at an economical price, and without the burden of contracts. We do not compromise on quality and do not believe our customers should either.

Micro-Tech Endoscopy has operations in America, Asia, and Europe and leverages this global reach to refine the products we provide to our partners. Our team has a wealth of experience in the field and an in-depth understanding of both product and use cases.

With the health care industry transforming rapidly, we dedicate ourselves to set the pace as a disruptor. At Micro-Tech, we are more than a medical technology company – we are building a community of healthcare innovators and making health care more value-driven.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."

Sedana Medical Completes Patient Recruitment for INSPiRE-ICU 1 Clinical Trial in the US

Peter Sackey further elaborated: "Once the 30-day follow-up of all patients is complete, we will enter into an intense phase of final monitoring, data cleaning and transfer to our statistician team for analysis. In parallel, the long-term outcomes at 3 and 6 months will be collected centrally by the Critical Illness, Brain Dysfunction, and Survivorship team at Vanderbilt Medical Center. With this parallel approach, we expect topline results in the autumn of this year and a swift regulatory submission in Q1, 2025".

Health / Lifestyle

Articles of Interest

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy